Skip to content
Search for:
COMPANY
PRODUCTS
R & D
Product Candidates Overview
Pipeline
Orphan Drug Designations
PARTNERING
INVESTOR RELATIONS
Press Releases
Events & Presentations
Stock Information
SEC Filings
XBRL Filings
Stockholder Meeting
Corporate Governance
Email Alerts
Investor Contact
CONTACT
SEC Filings
SEC Filings
AIM ImmunoTech
2020-03-31T11:27:19-04:00